Takara Bio Inc. (JP:4974) has released an update.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
- Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.
Takara Bio Inc. reported a modest increase in net sales for the first half of 2024, reaching ¥19,758 million, despite a notable drop in operating and ordinary profits compared to the previous year. The company’s financial position remains strong with a high equity-to-asset ratio, and it forecasts significant profit growth for the full fiscal year. Investors can anticipate stable dividends, maintaining the payout from the previous year.
For further insights into JP:4974 stock, check out TipRanks’ Stock Analysis page.